BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a partial cut-away, perspective view of an MRI system and medical device according to the present invention.
FIG. 2 is a top, perspective view of the medical device shown in FIG. 1.
FIG. 3 is an enlarged, perspective view of an exemplary tracking device used in the medical device shown in FIG. 2.
FIG. 4 is an enlarged, perspective view of an exemplary RF tracking coil and tube used in the tracking device shown in FIG. 3.
FIG. 5 is a graphic representation of the basic pulse sequence diagram used to acquire location data for a MR tracking device.
FIG. 6 is a graphic representation of the pulse sequence diagram in accordance with the present invention.
FIG. 7 is a flow chart of an exemplary algorithm used to practice the system and method of tracking a medical device using MR according to the present invention.
DETAILED DESCRIPTION OF THE INVENTION
As shown in FIG. 1 the MRI system 100 according to the present invention comprises an MRI machine 102, and a medical device 103 disposed within the bore of the MRI machine 102. The components and operation of the MRI machine are known in the art so only some basic components helpful in the understanding of the system 100 and its operation will be described herein.
The MRI machine 102 typically comprises a cylindrical electromagnet 104 which generates a static magnetic field within the bore 105 of the electromagnet 104. The electromagnet 104 generates a substantially homogeneous magnetic field within the imaging region 116 inside the magnet bore 105. The electromagnet 104 may be housed in a magnet housing 106. A support table 108 is disposed within the bore 105 of the magnet, upon which a patient 110 is placed. The patient is located with the volume of interest 118 within the patient 110 placed within the imaging region 116 of the MRI machine 102.
A set of cylindrical magnetic field gradient coils 112 are also provided within the bore of the magnet 104. The gradient coils 112 also surround the patient 110. The gradient coils 112 generate magnetic field gradients of predetermined magnitudes and at predetermined times, and in three mutually orthogonal directions within the magnet bore 105. An RF transmitter coil 114 surrounds a region of interest within the bore 105 which defines the imaging region 116. The RF transmitter coil 114 emits RF energy in the form of a magnetic field into the imaging region 116, including into the volume of interest 118 within the patient 110.
The RF transmitter coil 114 can also receive the MR response signal emitted by the spins which are resonating as a result of the RF pulse generated by the RF transmitter coil 114. The MR response signal that is received by the RF coil 114 is amplified, conditioned and digitized into data using an image processing system 200, as is known by those of ordinary skill in the art. The image processing system 200 further processes the digitized data using known computational methods, including fast Fourier transform (FFT), into an array of image data. The image data is then displayed on a monitor 202, such as a computer CRT, LCD display or other suitable display.
The medical device 103 is placed also within the imaging region 116 of the MRI machine 102. In the example shown in FIG. 1, the medical device 103 is an ultrasonic ablation instrument used for ablating tissue such as fibroids, cancerous or non-cancerous tissue, breaking up occlusion within vessels, or performing other treatment of tissues on or within the patient 110. Referring to FIG. 2, the medical device 103 has one or more tracking devices 122, in this case four tracking devices 122 are utilized. The tracking devices 122 are located at known positions on the medical device 103.
It should be understood that the medical device 103 can be any type of medical instrument including without limitation, a needle, catheter, guidewire, radiation transmitter, endoscope, laparoscope, or other instrument. In addition, the medical device 103 can be configured for placement external of the body of the patient 110, or for insertion into the patient, such as with a catheter. In the case of medical device intended for insertion into the patient 110, the tracking device(s) 122 can be located on the medical device such that the tracking device(s) 122 is inserted into the body of the patient 110, such as at the tip of a catheter or needle.
As shown in more detail in FIGS. 3 and 4, the tracking devices 122 comprise an RF tracking coil 124 wound around a tube 126. The RF coil 124 is formed of a conductive wire such as copper. The tube 126 may be formed of any suitable material, including glass, plastic polymers, etc. The tube 126 may be filled with oil, water or any other MR sensitive matter. The tube 126 and RF coil 124 are attached to a tracking device housing 128, formed of plastic or other suitable electrically non-conductive material.
In order to improve the transmission of the ultrasonic energy from the medical device 103, the medical device may be placed in a transducer housing 130 which is filled with an ultrasound transmission medium 132 such as de-gassed water, gel or other suitable medium.
The RF tracking coils 124 are electrically connected to the image processing system 200. The MR response signal received by the tracking devices 122 are amplified, conditioned and digitized into data using the image processing system 200. The image processing system 200 which processes the signal similar to the processing of the signal received by the RF coil 114, as described above. Alternatively, the RF tracking coils may be electrically connected to a second image processing system (not shown) which is separate from the image processing system 200. The second image processing system processes the MR response signal received by tracking devices 122 similarly to the image processing system 200. The second image processing system may transmits the resulting tracking data to the first image processing system, where it can be superimposed onto the display 202 with the image from the MRI system (i.e. produced from the signal received by the RF transmitting coil 114), or it can be displayed on a separate display from the display 202.
The position and orientation of the medical device 103 within the imaging region 116 relative to the patient volume of interest may be determined using the MRI machine 102 to image the volume of interest, and the tracking devices 122 to determine the location and orientation of the medical device 103. In operation, the MRI machine 102 activates the gradient coils 112, the RF transmitting coil 114 and the RF tracking coils using the pulse sequence diagram (PSD) as shown in FIG. 6. The presented pulse sequence diagram shown in FIG. 6. is conceptually only. The sequence should be repeated at least three times, each in a different readout gradient direction i.e. X, Y and Z to determine the tracking device projection on each axis. For each readout gradient direction the dephasing gradient direction selected to be perpendicular to the readout gradient direction and preferably along the longest axis of the MR sensitive material causing the interference. The PSD of FIG. 6 can be compared to the typical PSD which is shown in FIG. 5. In the modified PSD of FIG. 6, a dephasing gradient is applied perpendicular to readout gradient before the MR response signal is received by the RF tracking coils. The dephasing gradient is preferably applied along the longest axis of the material causing an interfering signal. In the present example, the volume of water, or other medium 132 surrounding the medical device 103, is the major source of interference. Accordingly, the longest axis of the material which may cause interference is the long axis of the volume of medium 132. The dephasing gradient strongly attenuates the interfering signal produced by the medium and any other source of interfering signal emanating from outside the close vicinity of the tracking devices 122. As explained above, the effect on the primary MR response signal produced by the material in the close vicinity of each RF tracking coil 124 is extremely small as compared to the attenuation effect on the interfering signal received by each RF tracking coil 124. In other words, the signal-to-noise ratio (SNR) of the primary MR response signal received by the RF tracking coils 124 is substantially increased by using the modified PSD.
The RF response signal received by each of the RF tracking coils 124 is then processed by the image processing system 200 using computational techniques generally known in the art. For example, referring to FIG. 7, a flow chart of an exemplary algorithm according to the present invention is shown. First, at step 300, the raw data files are read and arranged for each tracking device 122. The raw data comprises the conditioned and digitized data from the MR response signal received by each RF tracking coil 124. The raw data is processed using computational methods including FFT, to calculate the location of each tracking device 122 in the MR coordinates. The location information is then corrected to account for static magnetic field offset conditions (Bo), table position and for gradient non-linearity at steps 320 and 330, respectively. At step 340, the algorithm detects faults and errors in the individual and in the set of tracking devices' 122 location. The error detection is based on two different methods, SNR of each tracking device 122 and the distances between the devices. If the SNR of an individual tracking device 122 is found to be below a preset value the specific tracking device data is ignored and if the distance of a tracking device to other devices deviates from the known location of the tracking devices 122 the tracking device data is ignored also. At step 350, the final location of the medical device is calculated taking into account only the data from valid tracking devices. If not enough tracking devices' data are valid to determine the medical device location a new tracking scan is performed. This result is used to determine the new location of the medical device 103. The image on the display 202 is then updated based on the new tracking device location data. This process is repeated so long as tracking of the medical device 103 is needed.
While embodiments of the present invention have been shown and described, various modifications may be made without departing from the scope of the present invention. The invention, therefore, should not be limited, except to the following claims, and their equivalents.